In a move that is likely to ramp up its production and research capabilities, MGC Pharmaceuticals has signed a new, renegotiated, binding heads of agreement to acquire Czech-based medical cannabis company Panax Pharma. Under the deal, the Perth-based company will gain access to world-leading facilities in the Czech Republic for its medical cannabis research.